The reliability of disease severity assessment in psoriasis patients of color: Results of an educational intervention - 16/03/23
Doi : 10.1016/j.jaad.2022.10.025
Stephanie von Csiky-Sessoms, MD ⁎, Joel Correa Da Rosa, PhD, Joseph Han, BS, Danielle Dubin, MD, Mark Lebwohl, MD
Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York
∗Correspondence to: Stephanie von Csiky-Sessoms, MD, Icahn School of Medicine at Mount Sinai Department of Dermatology, 1 Gustave L Levy Place Box 1047, New York, NY 10029Icahn School of Medicine at Mount Sinai Department of Dermatology1 Gustave L Levy Place Box 1047New YorkNY10029
| Funding sources: None. |
|
| IRB approval status: Reviewed and exempted by Mount Sinai IRB; HS#: 18-00822. |
|
| Patient consent on file: Not applicable. |
|
| Key words: disease severity; psoriasis; skin of color. |
|
| Reprints not available from the authors. |
© 2022
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 88 - N° 4
P. 895-897 - avril 2023 Retour au numéro
Article précédent
- Psoriasis and COVID-19: A bidirectional Mendelian randomization study
- Christos V. Chalitsios, Kostas K. Tsilidis, Ioanna Tzoulaki
- Ocular adverse events associated with topical corticosteroid use in dermatology: A systematic review
- Jose W. Ricardo, Yu Wang, Wasim Haidari, Joseph L. Jorizzo
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?